Oxford Vacmedix UK Analysis: $20M Raised
What is Oxford Vacmedix UK?
Immunotherapy using recombinant overlapping peptides
HQ Country
Oxford, United Kingdom
Employees
1-10
Founded
2012
HQ State/Province
England
Product Features & Capabilities
- OVM-200
- OVM-100
- OVM-400
- AMR Diagnostic
How much Oxford Vacmedix UK raised
Funding - $20M
Other Considerations
Seeking Series B investment for clinical trials; Ongoing Phase 1 trial with strong preliminary data; Spinout from the University of Oxford
HQ Full Address
The Magdalen Centre, Oxford Science Park, Oxford, England OX4 4GA, United Kingdom
